Zemplar

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
NDA020819 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zemplar Is Indicated For The Prevention And Treatment Of Secondary Hyperparathyroidism In Patients 5 Years Of Age And Older With Chronic Kidney Disease (Ckd) On Dialysis. Zemplar Is A Vitamin D Analog Indicated For The Prevention And Treatment Of Secondary Hyperparathyroidism In Patients 5 Years Of Age And Older With Chronic Kidney Disease On Dialysis ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paricalcitol PARICALCITOL ZINC13911941

Comments